KUALA LUMPUR, Malaysia, Oct 5 (Bernama) — Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing.
Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%. The test kit works by detecting the presence of the coronavirus nucleocapsid protein in saliva samples. Infants under the age of two are not recommended to use this test kit.
- Hezbollah Official, Civilian Killed In Israeli Airstrike In Eastern Lebanon
- Egypt Honours Red Crescent Efforts For Gaza Humanitarian Aid; Latest Death Toll: 65,062 Palestinians
- Tunisia Hosts Arab Central Bank Governors’ Meeting
- Iran Executed Man Spying For Israel
- Nearly 48,000 Flee Israel’s Gaza City Ground Offensive In Last Two Days: UN
- Indonesian President Inaugurated New Ministers
- Only 13 Survived After Boat Carrying 74 Migrants Capsized Off Libya
- Putin, Modi Discussed Bilateral Ties, Ukraine In Phone Call
- China, Serbia Pledged To Enhance Legislative Cooperation
- Chinese Vice President Meets ASEAN Leaders Attending 22nd China-ASEAN Expo